Direktorat Registrasi ObatValid

BYFAVO

Claim this product
BPOM Number
DKI2615000244B1
Approved
8 April 2026
Expiry
18 March 2031
Form
SERBUK INJEKSI LIOFILISASI

About This Registration

BYFAVO is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2615000244B1. Its current registration status is Valid, with the licence valid until 18 March 2031. The product is registered to DEXA MEDICA - INDONESIA. BPOM first approved this registration in March 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 5 VIAL @ 50 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

REMIMAZOLAM BESYLATE

Market Intelligence

Owner Portfolio
DEXA MEDICA - INDONESIA holds 528 BPOM registrations
Manufacturer Scale
DEXA MEDICA - INDONESIA produces 528 registered products
Registration Age
Registered for 3 months

FDA Cross-Reference

via openFDA
Generic Name
REMIMAZOLAM BESYLATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1